Abstract:Purinergic signaling is a crucial determinant in the regulation of pulmonary vascular physiology and presents a promising avenue for addressing lung diseases. This intricate signaling system encompasses two primary receptor classes: P1 and P2 receptors. P1 receptors selectively bind adenosine, while P2 receptors exhibit an affinity for ATP, ADP, UTP, and UDP. Functionally, P1 receptors are associated with vasodilation, while P2 receptors mediate vasoconstriction, particularly in basally relaxed vessels, through modulation of intracellular Ca 2+ levels. The P2X subtype receptors facilitate extracellular Ca 2+ influx, while the P2Y subtype receptors are linked to endoplasmic reticulum Ca 2+ release. Notably, the primary receptor responsible for ATP-induced vasoconstriction is P2X1, with α,β-meATP and UDP being identified as potent vasoconstrictor agonists. Interestingly, ATP has been shown to induce endothelium-dependent vasodilation in pre-constricted vessels, associated with nitric oxide (NO) release. In the context of P1 receptors, adenosine stimulation of pulmonary vessels has been unequivocally demonstrated to induce vasodilation, with a clear dependency on the A 2B receptor, as evidenced in studies involving guinea pigs and rats. Importantly, evidence strongly suggests that this vasodilation occurs independently of endothelium-mediated mechanisms. Furthermore, studies have revealed variations in the expression of purinergic receptors across different vessel sizes, with reports indicating notably higher expression of P2Y 1 , P2Y 2 , and P2Y 4 receptors in small pulmonary arteries. While the existing evidence in this area is still emerging, it underscores the urgent need for a comprehensive examination of the specific characteristics of purinergic signaling in the regulation of pulmonary vascular tone, particularly focusing on the disparities observed across different intrapulmonary vessel sizes. Consequently, this review aims to meticulously explore the current evidence regarding the role of purinergic signaling in pulmonary vascular tone regulation, with a specific emphasis on the variations observed in intrapulmonary vessel sizes. This endeavor is critical, as purinergic signaling holds substantial promise in the modulation of vascular tone and in the proactive prevention and treatment of pulmonary vascular diseases.

P75 Neurotrophin Receptor Regulates Agonist-Induced Pulmonary Vasoconstriction.

Regulation of Low Affinity Neurotrophin Receptor (p75(ntr)) by Early Growth Response (egr) Transcriptional Regulators.

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Low Affinity Neurotrophin Receptor (p75ntr) Expression is Regulated by Early Growth Response (egr) Transcriptional Regulators

Effects of p75 neurotrophin receptor on regulating hypoxia-induced angiogenic factors in retinal pigment epithelial cells

Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone

Classical Transient Receptor Potential 1 and 6 Contribute to Hypoxic Pulmonary Hypertension Through Differential Regulation of Pulmonary Vascular Functions

Tumor Necrosis Factor Alpha Inhibits L-Type Ca(2+) Channels in Sensitized Guinea Pig Airway Smooth Muscle through ERK 1/2 Pathway

On the presence of neurotrophin p75 receptor on rat sympathetic cerebrovascular nerves

Purinergic regulation of pulmonary vascular tone

Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice

Genetic Dissection of Neurotrophin Signaling Through the P75 Neurotrophin Receptor.

Purinergic Dysregulation in Pulmonary Hypertension

Connexin 43 Plays a Role in Pulmonary Vascular Reactivity in Mice

[Changes of Nerve Growth Factor and Its Receptors in the Lung Tissues in Asthmatic Rats and Their Effects on the Airway Inflammation].

Trpc1 And Trpc6 Regulate Chronic Hypoxia-Induced Vascular Tone, Vasoreactivity And Pulmonary Hypertension

Trpv4 Channel Contributes To Serotonin-Induced Pulmonary Vasoconstriction And The Enhanced Vascular Reactivity In Chronic Hypoxic Pulmonary Hypertension

Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure

Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry.

Contributions of Trpv4 to Altered Pulmonary Vasoreactivity in Mice with Pulmonary Hypertension

NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivity